Clinical trial
Temozolomide in Treating Women With Advanced Breast Cancer
NCT00005054 · The Christie NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00005054 |
|---|---|
| Title | Temozolomide in Treating Women With Advanced Breast Cancer |
| Official title | Phase II Trial of Temodal 4 Hourly in Progressive Breast Cancer |
| Lead sponsor | The Christie NHS Foundation Trust, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | temozolomide |
| Start date | May 1, 1998 |
| First posted | Jun 8, 2004 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: